Browse press releases
The newest releases come first, each with its full text here and a link to its original. Try the filters to narrow them down.
- InventHelpInventHelp Inventor Develops Repositioning Device for Patients (MBQ-965)"I thought there could be a safer and more efficient way to reposition a patient within a bed," said an inventor, from Brooklyn, N.Y., "so I invented the NURSES WEEKEND. My design reduces the risk of injury to both the patient and the medical...
- ENvue Medical, Inc.ENvue Medical Provides Nasdaq Listing UpdateENvue Medical, Inc. (Nasdaq: FEED) (“ENvue” or the “Company”), a medical technology company focused on innovative solutions for enteral feeding and therapeutic ultrasound, today announced that it has received a decision from the Nasdaq Hearings Panel (the “Panel”) denying the Company’s request for continued listing on The Nasdaq Capital Market. As a result, trading of the Company’s common stock will be suspended and will begin trading on the OTC Markets under the same stock symbol, ‘FEED’, on September 16, 2026.
- OracleQuorum Health Unifies Enterprise, Financial, and Clinical Technology Platforms with OracleCompanies: Oracle CorporationQuorum Health has selected Oracle to standardize its technology across clinical, operational, and financial functions, creating a connected...
- Public Health Advocacy InstitutePUBLIC HEALTH ADVOCACY INSTITUTE (PHAI) AND FAMILIES AND FRIENDS OF GAMBLERS (FFOG) LAUNCH "TRUTH AND INTEGRITY: THE MOVEMENT FOR GAMBLING REFORM"National movement led by PHAI and FFOG will kick off on September 23, 2026, in Washington, D.C.; Truth and Integrity: The Movement for Gambling Reform will bring accountability and comprehensive federal and state regulation to the gambling industry, prediction markets and their sports and...
- AARD Shareholder Alert: Aardvark Therapeutics, Inc. Securities Class Action Lawsuit - Investors Should Contact SueWallStA securities class action alleges Aardvark Therapeutics' Chief Executive Officer, Chief Financial Officer, and former Chief Operating Officer controlled the safety representations about ARD-101 that preceded a Phase 3 pause and a full FDA clinical hold
- Lightbeam Health SolutionsLightbeam Health Appoints Thomas McCarrick, MD, MBI, as Chief Medical OfficerPracticing physician and healthcare executive brings more than four decades of experience in primary care, clinical informatics, population health, and value-based care — Lightbeam Health Solutions, a proven AI-enabled solutions and services leader...
- Mindray North AmericaMindray North America Advances Respiratory Care with the Launch of the SV70 Non-Invasive VentilatorFollowing the Philips V60 withdrawal, the SV70 offers respiratory departments a proven path forward built on clinical confidence and long-term standardization. — Mindray, a global leader in healthcare innovation across perioperative, medical...
- Fort Wayne Medical Oncology and Hematology and Fort Wayne Gynecologic Oncology Consolidate Bluffton and Decatur Clinics at New Decatur LocationFort Wayne Medical Oncology and Hematology and Fort Wayne Gynecologic Oncology Consolidate Bluffton and Decatur Clinics at New Decatur Location
- John Muir HealthJohn Muir Health Implements NPi-Connect to Reduce Nurse Burden and Support Patient CareElectronic health record-integrated technology condenses charting time so critical care nurses can spend more time at the bedside. — John Muir Health's Walnut Creek Medical Center has implemented the NPi-Connect™ connectivity hub...
- IXL LearningIYKYK: Dictionary.com's 2026 Summer Word Drop Captures the Language of Life Online5,900 new words reveal how the internet, AI, health, science and culture are reshaping English — If you know, you know. And if you don't—that's the meaning of the acronym in the headline, and one of the 5,900 words added to Dictionary.com....
- MAIA Biotechnology Announces Open Market Purchases of Company Stock by Long-Standing Board Member and CEOMAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing immunotherapies for cancer, today announced that Board member Ramiro Guerrero, JD, LL.M. has increased his ownership stake in the Company through open market purchases totaling approximately $252,284. A total of 185,078 shares of MAIA common stock were acquired by Mr. Guerrero between August 20, 2026, and September 10, 2026, at an average common stock price of $1.36. MAIA also announced that 73,000 shares of MAIA common stock were acquired by Founder and CEO Vlad Vitoc, M.D. on September 14, 2026, at an average common stock price of $1.37.
- Annals of Family MedicineAnnals of Family Medicine: Physician Warmth and Competence Shape How Patients Interpret Normal Test ResultsHow a physician communicates normal tests results may determine how the information lands with a patient, according to a study published in Annals of Family Medicine. The study was led by Tobias Kube, PhD, of Goethe University Frankfurt and...